APAC Molecular Diagnostics Market, Forecast to 2021

  • ID: 4209858
  • Report
  • Region: Asia Pacific
  • 191 pages
  • Frost & Sullivan
1 of 4
Pharmerging Economies with Rising Healthcare Demands will Accentuate Growth

FEATURED COMPANIES

  • Abbott
  • Becton Dickinson
  • BioMérieux
  • Illumina
  • Qiagen
  • Seegene
  • MORE

The molecular diagnostics (MDx) market in APAC is witnessing rapid growth due to two main factors: the high adoption of MDx tests for infectious diseases applications in emerging countries, and the advent of innovative diagnostic solutions in cancer and NGS based solutions that are gaining pace in Asia. Multinational companies have not only identified Asia as a market for future growth but have significantly invested in R&D efforts to cater to the Asian population. Genomic studies on Asian population in disease areas like oncology for targeted therapies are constantly on a rise, with active efforts from pharmaceutical and IVD companies. The rise of the private healthcare sector in Asia, with the improvement of socio-economic conditions and the growth of a wealthy middle class, has increased the quest for affordable and quality healthcare across the region.

The total MDx industry has been segmented into 4 major areas: infectious diseases, oncology, genetic disorders, and pharmacogenomics. The APAC MDx market was worth $1.72 Billion in 2016 and is expected to reach $2.86 Billion by 2021, at a CAGR of 10.7%. Infectious disease represents the highest market share of 72.0%, followed by oncology (14.3%), genetic disorders (10.0%) and pharmacogenomics (3.7%). Cancer incidence has gone up significantly in Asia. Under genetic disorders, non-invasive prenatal testing (NIPT) has great potential with excellent opportunities for future growth. On the technology front, conventional PCR technology is being upgraded with multiplexing capabilities and introduction of automated solutions to cater to high volumes. NGS solutions are gradually making inroads into Asia, especially in developed markets like Singapore, Japan, and South Korea.

This study highlights the growing prominence of MDx industry in Asia, regional trends, growth opportunities, competitive dynamics, and a regional chapter for each of the 11 countries covered in this study.

Area of opportunity in MDx market in the APAC:

- The MDx market in the APAC is evolving with increasing access to established NATs in emerging countries as a result of revamped healthcare practices across the region.

- Oncology care has taken a new dimension in APAC, with the simultaneous rise in prevalence and demand for innovative drugs beyond conventional chemotherapy drugs.

- CDx based oncology drugs are on the rise in the region, with studies targeted for Asian population to demonstrate value. For example, Ono Pharmaceutical’s research on identifying a CDx for Opdivo, introduced in 2014 to stratify patient population.

- Novel genomic tools and technologies are foraying into the APAC to harness the future growth opportunities in the dynamic healthcare ecosystem.

Key questions this study will answer:

- What is the impact of MDx on the IVD industry, given the present healthcare scenario in the APAC?

- Who are the key industry participants in this highly fragment market?

- What are multiple factors impending the growth of MDx in the APAC?

- What are the service delivery models adapted by stakeholders across this region?

- What are the market access strategies for MDx companies aspiring to enter the APAC?

- What is the future of the molecular diagnostics market in the APAC?

READ MORE
Note: Product cover images may vary from those shown
2 of 4

FEATURED COMPANIES

  • Abbott
  • Becton Dickinson
  • BioMérieux
  • Illumina
  • Qiagen
  • Seegene
  • MORE
1. Executive Summary
Key Findings
Scope and Segmentation
Market Overview—Key Questions
Market Engineering Measurements
Market Overview—Definitions
8 Big Market Themes for APAC MDx
Trends/Factors Impacting the APAC MDx Market
Key Companies to Watch
Key Predictions
MDx—Transition from Present to Future

2. Market Overview
Market Segmentation
Market Overview—Segmentation by Application
Role of Molecular Biomarkers in Pharma R&D
Market Overview—Life Cycle Analysis

3. Competitive Playbook
Competitive Playbook
Key Mergers, Acquisitions, & Partnerships

4. Drivers and Restraints—Total Molecular Diagnostics Market
Market Drivers
Drivers Explained
Market Restraints
Restraints Explained

5. Forecast and Trends—Total Molecular Diagnostics Market
Market Engineering Measurements
Total Molecular Diagnostics Market—Revenue Forecast
Revenue Forecast Discussion
Percent Revenue Forecast by Country
Revenue Forecast by Country
Snapshot of Market Participants
Market Snapshot

6. Competitive Environment
Market Share by Companies
Competitive Positioning—Seegene
Competitive Positioning—Roche
Competitive Positioning—ThermoFisher
Competitive Positioning—Qiagen
Competitive Positioning—Sysmex

7. Growth Opportunities
Growth Opportunities—Synergy of 3Ps in APAC
Growth Opportunities—Clinical Trials Market in APAC
Growth Opportunities
Trends for the Adoption of MDx Services in APAC
Future Trends—Direct to Consumer Testing
Future Trends—Niche Clusters to Watch Out for
Future Trends—Point-of-Care Testing (POCT) in MDx
Future Trends—Lifestyle Genomics in APAC
Genome Asia-100K

8. Technology Segments—An Overview
Polymerase Chain Reaction (PCR)
PCR—Technology Snapshot
In-situ Hybridization (ISH)
Next-Generation Sequencing (NGS)
Cost Implications of NGS
Future of NGS Platform
Drivers for Technology Platforms
MDx Test by Application Scenarios

9. Clinical Application Segment Analysis—Infectious Disease Segment
Infectious Disease Segment—Revenue Forecast
Revenue Forecast Discussion

10. Oncology Segment
Oncology Segment—Revenue Forecast
Revenue Forecast Discussion

11. Genetic Disorders Segment
Genetic Disorders Segment—Revenue Forecast
Revenue Forecast Discussion

12. Pharmacogenomics Segment
Pharmacogenomics Segment—Revenue Forecast
Revenue Forecast Discussion

13. Regional Forecast Trends and Opportunities—China Molecular Diagnostics Market
Market Engineering Measurements
China Market—Revenue Forecast
Revenue Forecast Discussion
China—Market Drivers
China—Market Restraints
Competitive Structure

14. South Korea Molecular Diagnostics Market
Market Engineering Measurements
South Korea Market—Revenue Forecast
Revenue Forecast Discussion
South Korea—Market Drivers
South Korea—Market Restraints
Competitive Structure

15. India Molecular Diagnostics Market
India Molecular Diagnostics Market
Market Engineering Measurements
India Market—Revenue Forecast
Revenue Forecast Discussion
India—Market Drivers
India—Market Restraints
Competitive Structure

16. Japan Molecular Diagnostics Market
Japan Molecular Diagnostics Market
Market Engineering Measurements
Japan Market—Revenue Forecast
Revenue Forecast Discussion
Japan—Market Drivers
Japan—Market Restraints
Competitive Structure

17. Australia Molecular Diagnostics Market
Australia Molecular Diagnostics Market
Market Engineering Measurements
Australia Market—Revenue Forecast
Revenue Forecast Discussion
Australia—Market Drivers
Australia—Market Restraints
Competitive Structure

18. Taiwan Molecular Diagnostics Market
Taiwan Molecular Diagnostics Market
Market Engineering Measurements
Taiwan Market—Revenue Forecast
Revenue Forecast Discussion
Taiwan—Market Drivers
Taiwan—Market Restraints
Competitive Structure

19. Indonesia Molecular Diagnostics Market
Indonesia Molecular Diagnostics Market
Market Engineering Measurements
Indonesia Market—Revenue Forecast
Revenue Forecast Discussion
Indonesia—Market Drivers
Indonesia—Market Restraints
Competitive Structure

20. Malaysia Molecular Diagnostics Market
Malaysia Molecular Diagnostics Market
Market Engineering Measurements
Malaysia Market—Revenue Forecast
Revenue Forecast Discussion
Malaysia—Market Drivers
Malaysia—Market Restraints
Competitive Structure
Key Trends—Challenges and Opportunities

21. Thailand Molecular Diagnostics Market
Thailand Molecular Diagnostics Market
Market Engineering Measurements
Thailand Market—Revenue Forecast
Revenue Forecast Discussion
Thailand—Market Drivers
Thailand—Market Restraints
Competitive Structure

22. Singapore Molecular Diagnostics Market
Singapore Molecular Diagnostics Market
Market Engineering Measurements
Singapore Market—Revenue Forecast
Revenue Forecast Discussion
Singapore—Market Drivers
Singapore—Market Restraints
Competitive Structure

23. Philippines Molecular Diagnostics Market
Philippines Molecular Diagnostics Market
Market Engineering Measurements
Philippines Market—Revenue Forecast
Revenue Forecast Discussion
Philippines—Market Drivers
Philippines—Market Restraints
Competitive Structure

24. Vietnam Molecular Diagnostics Market
Vietnam Molecular Diagnostics Market
Market Engineering Measurements
Vietnam Market—Revenue Forecast
Revenue Forecast Discussion
Vietnam—Market Drivers
Vietnam—Market Restraints
Competitive Structure

25. Conclusion
Note: Product cover images may vary from those shown
3 of 4

Loading
LOADING...

4 of 4
  • Abbott
  • Agilent
  • BGI
  • Becton Dickinson
  • Bio-Rad
  • BioMérieux
  • Illumina
  • Perkin Elmer
  • Qiagen
  • Roche
  • Seegene
  • Sysmex
  • Thermofisher
Note: Product cover images may vary from those shown
5 of 4
Note: Product cover images may vary from those shown
Adroll
adroll